AR025713A1 - USE OF CERTAIN SOAPS OF FATTY ACIDS / AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION - Google Patents

USE OF CERTAIN SOAPS OF FATTY ACIDS / AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION

Info

Publication number
AR025713A1
AR025713A1 ARP000104901A ARP000104901A AR025713A1 AR 025713 A1 AR025713 A1 AR 025713A1 AR P000104901 A ARP000104901 A AR P000104901A AR P000104901 A ARP000104901 A AR P000104901A AR 025713 A1 AR025713 A1 AR 025713A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
topical administration
amino acids
fatty acids
antimicrobial effectiveness
Prior art date
Application number
ARP000104901A
Other languages
Spanish (es)
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of AR025713A1 publication Critical patent/AR025713A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se usan jabones de ácidos grasos / aminoácidos para mejorar la eficacia antimicrobiana en composiciones farmacéuticas de administracion topica quecontienen por o menos un ingrediente activo, un preservante cationico y un polielectrolito anionico, tales como un polímero de carboxivinilo, goma de xantano,polímero de ácido sulfonico de poliestireno o resina de intercambio cationico.Fatty acid / amino acid soaps are used to improve antimicrobial efficacy in topical administration pharmaceutical compositions containing at least one active ingredient, a cationic preservative and an anionic polyelectrolyte, such as a carboxyvinyl polymer, xanthan gum, sulfonic acid polymer of polystyrene or cation exchange resin.

ARP000104901A 1999-09-21 2000-09-19 USE OF CERTAIN SOAPS OF FATTY ACIDS / AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION AR025713A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39901399A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
AR025713A1 true AR025713A1 (en) 2002-12-11

Family

ID=23577764

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104901A AR025713A1 (en) 1999-09-21 2000-09-19 USE OF CERTAIN SOAPS OF FATTY ACIDS / AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION

Country Status (10)

Country Link
EP (1) EP1214094A1 (en)
JP (1) JP2003509474A (en)
CN (1) CN1374874A (en)
AR (1) AR025713A1 (en)
AU (1) AU7363700A (en)
BR (1) BR0014117A (en)
CA (1) CA2391976A1 (en)
PL (1) PL354365A1 (en)
TR (1) TR200200724T2 (en)
WO (1) WO2001021209A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444710B1 (en) 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
TWI231759B (en) 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
FR2837710B1 (en) * 2002-03-26 2005-07-08 Innovations Pharma Ag TOPICAL COMPOSITION BASED ON ION-EXCHANGE RESINS, IN PARTICULAR FOR THE TREATMENT OF ERYTHEMES
US10918618B2 (en) * 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
WO2012026609A1 (en) * 2010-08-27 2012-03-01 わかもと製薬株式会社 Aqueous composition for ophthalmic administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209722C3 (en) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Dripable gel for ophthalmology
US5520920A (en) * 1992-08-28 1996-05-28 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
JPH0977725A (en) * 1995-09-13 1997-03-25 Ajinomoto Co Inc Production of lysine salt of fatty acid
DE69904498T2 (en) * 1998-10-27 2003-04-24 Alcon Lab Inc PRESERVATIVES FOR LOCAL PHARMACEUTICAL PREPARATIONS CONTAINING A SOAP CONTAINING FATTY ACID / AMINO ACID

Also Published As

Publication number Publication date
EP1214094A1 (en) 2002-06-19
PL354365A1 (en) 2004-01-12
AU7363700A (en) 2001-04-24
WO2001021209A1 (en) 2001-03-29
CN1374874A (en) 2002-10-16
JP2003509474A (en) 2003-03-11
TR200200724T2 (en) 2002-06-21
CA2391976A1 (en) 2001-03-29
BR0014117A (en) 2002-05-14

Similar Documents

Publication Publication Date Title
AR025712A1 (en) USE OF CERTAIN SURFACTANTS BASED ON ANIONIC AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION
ES2703505T3 (en) Combination of adapalene and benzoyl peroxide to treat acne lesions
RU2521248C2 (en) Borinic compositions
BRPI0406911A (en) Pharmaceutical and / or cosmetic product
BRPI0508933A (en) compositions for topical delivery
AR038575A1 (en) OPHTHALM FORMULATION WITH NEW RUBBER COMPOSITION
AR029716A1 (en) DERMATOLOGICAL PRODUCTS IN SHEET FORM
DE60122312D1 (en) MEMBRANE ADMINISTRATION SYSTEM FOR ACTIVE SUBSTANCES
ES2478264T3 (en) Glyerosomes and their use in pharmaceutical and cosmetic preparations for topical application
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
ME00298B (en) Pharmaceutical composition
CA2484184A1 (en) Minoxidil foam formulation
AR020392A1 (en) MICROENCAPSULATED FORMULATIONS.
BR0015256A (en) Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and a xanthan gum
ES2111717T3 (en) USE OF CERTAIN ANIONIC SURFACES TO INCREASE THE ANTIMICROBIAL EFFICACY OF OPHTHALMIC COMPOSITIONS.
AR025713A1 (en) USE OF CERTAIN SOAPS OF FATTY ACIDS / AMINO ACIDS TO IMPROVE ANTIMICROBIAL EFFECTIVENESS OF PHARMACEUTICAL COMPOSITIONS OF TOPICAL ADMINISTRATION
EP2445483B1 (en) Topical compositions and methods for wound care
AR052882A1 (en) ANTIHELMINTIC COMPOSITION
CA2104917A1 (en) Use of Certain Anionic Surfactants to Enhance Antimicrobial Effectiveness of Ophthalmic Compositions
NO20045700L (en) Oral pharmaceutical preparations including ion exchange resins with active substance addition and pseudoplastic gelling thickeners
BRPI0518554A2 (en) use of a pde3 inhibitor
BRPI0411702B8 (en) use of hyaluronic acid to prepare compositions for the treatment of thrush of the oral cavity
WO2014042604A1 (en) Clindamycin phosphate, salicylic acid and tea tree oil combinations
ES2150404T1 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITOZOXANIDE.
JP4643800B2 (en) Protease inhibitor